Axogen Inc (AXGN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Axogen inc   (NASDAQ: AXGN)
 

Axogen Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Axogen Inc inventory turnover ratio, the Axogen Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.45 in the second quarter 2026, AXGN's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Axogen Inc in Jun 30 2026 quarter, has decreased to 252 days, compare to 253 days, in the Mar 31 2026 quarter.

Within Healthcare sector 264 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1728, from total ranking in the first quarter 2026 at 1863.

AXGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Axogen Inc Market Share?

What is Inventory Turnover Ratio?




AXGN Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 28.66 % 29.77 % 27.69 % 38.2 % 31.27 %
Y / Y Cost of Sales Growth 30.14 % 12.04 % 30.98 % 15.43 % 16.53 %
Inventory Turnover Ratio (TTM) 1.45 1.44 1.49 1.48 1.55
AXGN's Total Ranking # 1728 # 1863 # 1788 # 1768 # 1748
Average inventory processing period 252 254 245 246 235
Seq. Inventory Growth 2.69 % 8.73 % 4.42 % 10.35 % 3.58 %
Seq. Cost of Sales Growth 24.82 % -1.46 % 9.98 % -3.79 % 7.46 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 265
Overall Market # 1728

Inventory Turnover Ratio Statistics
High Average Low
2.18 1.36 0.65
(Dec 31 2018)   (Sep 30 2012)




Financial Statements
Axogen Inc 's Inventories $ 47 Millions Visit AXGN's Balance sheet
Axogen Inc 's Cost of Revenues TTM $ 64 Millions Visit AXGN's Income Statement
What are AXGN's Sales? Visit AXGN's Sales by Segment

Other Inventory Turnover Ratios
Axogen Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AXGN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AXGN's Competitors
Inventory Turnover Ratio for AXGN's Suppliers
Inventory Turnover Ratio for AXGN's Customers

You may also want to know
AXGN's Sales Growth Rates AXGN's Pe Price to earnings ratio AXGN's Receivables Turnover Ratio AXGN's Stock Quote
AXGN's Net Income Growth Rates AXGN's Ps Price to Sales ratio AXGN's Sales per Employee AXGN's Asset Turnover Ratio
AXGN's Net Margin AXGN's Pb Price to Book ratio AXGN's Financial Strength Ratios AXGN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions

Date modified: 2026-08-13T04:56:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.